Cases 31 - 37 of 37
Value Drug Company et al v. AstraZeneca PLC et al
as 1:2012cv12293
Plaintiff:
Value Drug Company and Burlington Drug Company Inc.
Defendant:
AstraZeneca PLC, Atrazeneca LP , Atrazeneca Ab and others
Cause Of Action: 15 U.S.C. § 1 Antitrust Litigation
In Re: Nexium (Esomeprazole) Antitrust Litigation
as 1:2012md02409
Plaintiff:
International Brotherhood Of Electrical Workers Local 595 Health And Welfare Fund, All Plaintiffs, New York Hotel Trades Council and Hotel Assoc. of New York City, Inc. Health Benefits Fund and others
Interested Party:
CaremarkPCS Health, LLC, Value Drug Company, McKesson Corporation and others
Consolidated Plaintiff:
A.F. of L. - A.G.C. Building Trades Welfare Plan, ARCADIAN HEALTH PLAN OF LOUISIANA, INC., CARITEN INSURANCE COMPANY and others
Intervenor:
Express Scripts, Inc., Christopher Wirth, Edward Breivik and others
Defendant:
Dr. Reddy's Laboratories, Inc., Ranbaxy Pharmaceuticals, Inc., TEVA USA, INC. and others
Intervenor Plaintiff:
Amerisourcebergen Drug Corporation
Petitioner:
Mr. TIMOTHY C. HESTER
In Re:
Nexium (Esomeprazole) Antitrust Litigation
Cause Of Action: 15 U.S.C. § 1 Antitrust Litigation
LOUISIANA WHOLESALE DRUG CO., INC. v. SMITHKLINE BEECHAM CORPORATION et al
as 2:2012cv00995
Defendant:
TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICALS, GLAXOSMITHKLINE LLC formerly SmithKline Beecham Corp. d/b/a/ GlaxoSmithKline and others
Interested Party:
MEIJER INC.
Amicus Curiae:
FEDERAL TRADE COMMISSION
Lead Plaintiff:
KING DRUG COMPANY OF FLORENCE, INC., LOUISIANA WHOLESALE DRUG CO., INC. and ROCHESTER DRUG CO-OPERATIVE, INC.
Not Yet Classified:
MEIJER DISTRIBUTION, INC., MORRIS & DICKSON CO., L.L.C., FWK HOLDINGS LLC and others
Cause Of Action: 15 U.S.C. § 1 Antitrust Litigation
Burlington Drug Company Inc. v. Astellas Pharma US, Inc.
as 1:2011cv11025
Plaintiff:
Burlington Drug Company Inc.
Defendant:
Astellas Pharma US, Inc.
Cause Of Action: 15 U.S.C. § 2
Burlington Drug Company Inc. v. Astellas Pharma US, Inc.
as 1:2011cv00228
Plaintiff:
Burlington Drug Company Inc.
Defendant:
Astellas Pharma US, Inc.
Cause Of Action: 15 U.S.C. § 2
BURLINGTON DRUG COMPANY, INC. et al v. ASTRAZENECA PHARMACEUTICALS L.P. et al
as 1:2007cv00041
Plaintiff:
BURLINGTON DRUG COMPANY, INC., BURLINGTON DRUG COMPANY, INC., BURLINGTON DRUG COMPANY, INC. and others
Defendant:
ASTRAZENECA PHARMACEUTICALS L.P., ASTRAZENECA PHARMACEUTICALS L.P., ASTRAZENECA PHARMACEUTICALS L.P. and others
Cause Of Action: 15 U.S.C. § 2 Antitrust Litigation
KING DRUG COMPANY OF FLORENCE, INC vs. CEPHALON, INC., ET AL
as 2:2006cv01797
Plaintiff:
AMERICAN SALES CO., INC., BURLINGTON DRUG COMPANY, INC., CVS CAREMARK CORPORATION and others
Defendant:
BARR LABORATORIES, INC., BARR PHARMACEUTICALS, INC., CEPHALON, INC. and others
Petitioner:
TADEKA PHARMACEUTICAL NORTH AMERICA, INC.
Cause Of Action: 15 U.S.C. § 15 Antitrust Litigation
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
